
iPrescribe Pricing Plans & Top Alternatives in 2026
Innovative, secure, and convenient prescription writing.
Trusted by 254,745+ software buyers annually.
Main Features
- DEA-Detection
- Monitoring
- Real Time Analytics
Pricing
Starts from $30/Month
iPrescribe Pricing
Free Trial
Not available
Starting Price
$30 / /Month
Pricing Model
iPrescribe Pricing Plans Explained
Need a plan for 50+ users?
Get volume pricing, dedicated onboarding, and a custom contract. Switching from another tool? iPrescribe supports data import to get you set up quickly.
Pricing sourced from iPrescribe's official website as of May 2026. For the latest pricing, visit their website.
Frequently Asked Questions (FAQs)
Stuck on something? We're here to help with all the questions and answers in one place.
iPrescribe does not offer a free trial or free plan. All plans are paid. Contact the iPrescribe team for a demo or visit their pricing page for current options.
iPrescribe offers Subscription pricing. Plans start from $30//Month. View all iPrescribe pricing plans →
The starting price of iPrescribe is $30/Month
iPrescribe does not currently offer a free plan. All plans are paid. Visit the pricing page to see current options.
Most subscription-based tools including iPrescribe offer a discount when you choose annual billing over monthly. Annual plans typically save 15–40% compared to paying month-to-month. Check iPrescribe's pricing page for exact savings.
Most SaaS products including iPrescribe allow you to cancel your subscription at any time. For monthly plans, cancellation typically takes effect at the end of the current billing cycle. For annual plans, refund policies vary — check iPrescribe's terms or contact their support team for details.
iPrescribe offers tiered pricing plans designed for teams of different sizes. Small businesses can typically start with a lower-tier plan and upgrade as they scale. See all plans to find the best fit.
iPrescribe Support Options
Disclaimer: This research has been collated from a variety of authoritative sources. We welcome your feedback at [email protected].














